<DOC>
	<DOCNO>NCT01452022</DOCNO>
	<brief_summary>This open-label non-randomised , prospective , post market study evaluate performance Inductigraft ( osteoinductive synthetic bone graft ) patient receive posterolateral lumbar spine fusion assessment successful fusion 12 month post operation use x-rays CT scan . Quality life questionnaire also use assess clinical outcome measure pain quality life . Patients follow 24 month surgery .</brief_summary>
	<brief_title>Performance Inductigraft Spinal Fusion</brief_title>
	<detailed_description />
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Diagnosed Degenerative Disk Disease ( DDD ) lumbar spinal stenosis one two continuous spinal level ( ) , include subject spondylolisthesis ( i.e . degenerative isthmic ) Has fail least six month nonoperative treatment prior clinical trial enrolment candidate spinal fusion surgery one two vertebral level , include , L2 S1 ( i.e . second lumbar first sacral ) ≥ 18 year old skeletally mature ( epiphysis close ) Is , Investigator 's opinion , psychosocially , mentally , physically able fully comply protocol , include postoperative regimen , require follow visit , fill require form , ability understand give write informed consent . Has diagnosis symptomatic DDD , spondylolisthesis , lumbar spinal stenosis two level Has prior fusion surgery lumbar level Has systemic infection infection surgical site History significant metabolic bone disease osteomalacia , autoimmune disease include rheumatoid arthritis , renal disease , hepatic disease , peripheral vascular disease , insulin dependent diabetes , Paget 's disease involve spinal level ( ) upper motor neuron disease ( positive Babinski sign ) Has medical condition would interfere postoperative assessment care ( i.e . psychiatric disease , paraplegia , quadriplegia , etc . ) Is poor general health concurrent disease process would place subject excessive risk surgery ( e.g . significant circulatory , pulmonary problem , cardiac disease ) Has history ( present past ) substance abuse ( recreational drug , prescription drug alcohol ) Investigator 's opinion may interfere protocol assessment and/or subject 's ability complete protocol require follow Is know pregnant/breastfeeding time enrollment , plan become pregnant course clinical trial Is participate , complete within last 30 day , another investigational clinical trial , could confound result Has three prior decompressive surgery , prior posterior lumbar surgery result significant muscle/ligament morbidity . This NOT include facet save technique discectomy , laminotomy , intradiscal procedure include nucleotomy , IDET procedures annuloplasty procedure Has back leg pain unknown cause Morbid obesity define Body Mass Index ( BMI ) ≥ 40 Nondiscogenic nonstenotic cause symptom ( e.g . tumour fracture involve level ) Has condition require postoperative medication may interfere bone/soft tissue healing ( i.e . oral parenteral glucocorticoid , immunosuppressive , methotrexate , etc . ) , effect rate bone metabolism unless undergone 14 day wash period prior surgery Is undergo treatment osteoporosis ( exclude osteopenia ) Investigator 's opinion , spinal instrumentation would contraindicate Is involved ongoing litigation , concern medical condition . Has know allergy silicon .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>inductigraft</keyword>
	<keyword>osteoinductive</keyword>
	<keyword>synthetic bone graft</keyword>
	<keyword>posterolateral lumbar fusion</keyword>
	<keyword>post market</keyword>
	<keyword>lumbar spinal stenosis</keyword>
</DOC>